As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for ...

Incidence of major adverse cardiovascular events (MACE) declined across every income group in Denmark from 1988 to 2023, but ...

Samantha Pettigrew, MD, explains blood clot risk factors, treatment, and return to play in the wake of the news of Jalen ...

Among the 100 recipients, median time from prescription to first injection was 12 days (interquartile range [IQR], 6-23). In ...

The uninsured rate among US adults aged 19 to 64 years rose from 8.9% in 2024 to 11.2% in 2026, a statistically significant ...

The US has curative HCV treatment and rapid tests but lags peer nations in prevention for people who inject drugs. The US is ...

People with arrhythmogenic cardiomyopathy (ACM) may face increased risk of ventricular arrhythmias and worsening heart ...

Myeloma faculty from UT Southwestern Medical Center and pharmacy leaders from Texas Oncology discussed how teclistamab- and ...

Universal HCV testing in pregnancy, DAA therapy, and earlier infant RNA testing can curb mother-to-child hepatitis C ...

The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, ...

Pharmacies are an emerging setting. In a claims analysis covering 2010 to 2017, pharmacists administered a small share of ...

Brensocatib hydrate (Brinsupri; Insmed Inc) launched commercially in Japan on October 19 for adults and children 12 years and ...